After 5 Years, Heated Controversy Persists In Science Copyright Case

Weissmann v. Freeman battle is revived as Dingell subcommittee decides to launch a new investigation Since the age of two, Heidi Weissmann says, she always wanted to be a doctor. She started college when she was 15, began medical school when she was 19, and by age 30 her supervisor was calling her one of the nation's premier authorities on biliary imaging in nuclear medicine. Yet now, at age 41, Weissmann is unemployed. Since 1987, she has claimed the United States radiological community has b

Written byRon Kaufman
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


Weissmann v. Freeman battle is revived as Dingell subcommittee decides to launch a new investigation
Since the age of two, Heidi Weissmann says, she always wanted to be a doctor. She started college when she was 15, began medical school when she was 19, and by age 30 her supervisor was calling her one of the nation's premier authorities on biliary imaging in nuclear medicine.

Yet now, at age 41, Weissmann is unemployed. Since 1987, she has claimed the United States radiological community has blackballed her from continuing her research. This summer, the case took a new turn, when Congress began investigating her charges for the second time. Weissmann's situation involves a five-year legal battle against her former employer, Montefiore Medical Center in Bronx, N.Y., over sex discrimination, and against her former lab chief, Leonard Freeman, a professor of nuclear medicine, over copyright infringement. Her story has compelled House Energy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies